Autoimmune lymphoproliferative syndrome with FAS mutations (ALPS-FAS) is also associated with hyperactivation of the mTOR pathway but hematologic symptoms are more severe than ALPS-CED. This evidence concerns the gene MTOR and autoimmune lymphoproliferative syndrome.